FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

896700009: Tafasitamab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2021. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
4028720015 Tafasitamab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
4028721016 Tafasitamab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tafasitamab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Tafasitamab Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing tafasitamab (medicinal product) Has active ingredient True Tafasitamab Inferred relationship Existential restriction modifier 1
Tafasitamab Has active ingredient True Tafasitamab Inferred relationship Existential restriction modifier 1
Product containing only tafasitamab in parenteral dose form (medicinal product form) Has active ingredient True Tafasitamab Inferred relationship Existential restriction modifier 1
Product containing tafasitamab in parenteral dose form (medicinal product form) Has active ingredient True Tafasitamab Inferred relationship Existential restriction modifier 1
Tafasitamab 200mg powder for solution for infusion vials Has specific active ingredient True Tafasitamab Inferred relationship Existential restriction modifier
Minjuvi 200mg powder for concentrate for solution for infusion vials (Incyte Biosciences UK Ltd) Has specific active ingredient True Tafasitamab Inferred relationship Existential restriction modifier
Tafasitamab 200mg powder for solution for infusion vials 1 vial Has specific active ingredient True Tafasitamab Inferred relationship Existential restriction modifier
Minjuvi 200mg powder for concentrate for solution for infusion vials (Incyte Biosciences UK Ltd) 1 vial Has specific active ingredient True Tafasitamab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start